Drug Discovery World

JULY 11, 2023

Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. The post Big data – charting a new path to drug discovery and development appeared first on Drug Discovery World (DDW).

Big Data 40

Big Data Development Life Science Drugs 40

pharmaphorum

SEPTEMBER 16, 2022

A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”. Verily’s Immune Profiler can, Kim asserted, “generate more than 8 million immune measures across 24 immune cell subsets”.

Development 134

Development Research Drugs Clinical Trials 134

Drug Discovery World

DECEMBER 27, 2023

A deep dive into US drug discovery What lies in the future for genomics and big data? and seizure liability testing What are the benefits of a target safety assessment?

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

Drug Discovery World

FEBRUARY 6, 2024

Sanofi has stated that it intends to become the first pharma company “powered by AI at scale”, and as part of this ambition, agreed a collaboration with BioMap to co-develop advanced AI models and protein Large Language Models that that it hopes will enable biologics design and multiparametric optimisation 2.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

pharmaphorum

DECEMBER 8, 2022

The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation.

Big Data 87

Big Data Gene Therapy Medicine Marketing 87

pharmaphorum

SEPTEMBER 18, 2020

The same year, AZ also entered into its third collaboration agreement with Astex Therapeutics, this time to develop small-molecule protein kinase B (PKB) to further contribute in the fight against cancer. AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company, for £120 million in 2005.

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113